Wealthspire Advisors LLC Trims Position in iShares Biotechnology ETF (NASDAQ:IBB)

Wealthspire Advisors LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 26.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,840 shares of the financial services provider’s stock after selling 4,243 shares during the period. Wealthspire Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,565,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at $29,000. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF during the 3rd quarter worth about $30,000. HHM Wealth Advisors LLC increased its position in iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at about $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $34,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.1 %

NASDAQ IBB opened at $138.74 on Tuesday. The firm’s 50 day moving average price is $135.64 and its 200-day moving average price is $140.77. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.